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 ABSTRACT 
 An erythromycin-resistant strain of probiotic Lac-
tobacillus paracasei ssp. paracasei LBC-1 (LBC-1e) 
was added to part-skim Mozzarella cheese in alginate-
microencapsulated or free form at a level of 108 and 107
cfu/g, respectively. Survival of LBC-1e and total lactic 
acid bacteria (LAB) was investigated through the pasta 
filata process of cheese making (in which the cheese curd 
was heated to 55°C and stretched in 70°C-hot brine), 
followed by storage at 4°C for 6 wk and simulated gas-
tric and intestinal digestion. This included incubation 
in 0.1 M and 0.01 M HCl, 0.9 M H3PO4, and a simulated 
intestinal juice consisting of pancreatin and bile salts 
in a pH 7.4 phosphate buffer. Some reductions were 
observed in both free and encapsulated LBC-1e dur-
ing heating and stretching, with encapsulated LBC-1e 
surviving slightly better. Changes in total LAB losses 
during heating and stretching did not reach statistical 
significance. During storage, a decrease was observed in 
total LAB, but no statistically significant decrease was 
observed in LBC-1e. Survival during gastric digestion 
in HCl was dependent on the extent of neutralization 
of HCl by the cheese, with more survival in the weaker 
acid, in which pH increased to 4.4 after cheese addition. 
The alginate microcapsules did not provide any protec-
tion against the HCl. It is interesting that survival of 
the encapsulated LBC-1e was greater during incubation 
in H3PO4 than in the HCl gastric juices. Proper selec-
tion of simulated gastric digestion media is important 
for predicting the delivery of probiotic bacteria into the 
human intestinal tract. Neither free nor encapsulated 
LBC-1e was affected by incubation in the pancreatin-
bile solution. Based on the level of probiotic bacteria in 
cheese needed to provide a health benefit and its sur-
vival during simulated gastric digestion, as determined 
in this study, it should theoretically be possible to lower 
the amount that needs to be ingested in cheese by up 
to a factor of 103 compared with other fermented dairy 
foods or when consumed as supplements. 
 Key words:   microencapsulation ,  probiotic ,  Mozza-
rella ,  cheese ,  gastric 
 INTRODUCTION 
 Probiotics are live microorganisms that, when admin-
istered in adequate amounts (106 to 107 cfu/g), confer 
a health benefit on the host (FAO/WHO, 2002). Pro-
biotics may be consumed either as a food component 
or as a nonfood preparation. Foods containing such 
bacteria fall within the functional foods category, and 
these are described as foods claimed to have a positive 
effect on health. However, for a probiotic bacterium to 
provide a benefit to human health, it must fulfill several 
criteria. It must have good technological properties so 
that it can be manufactured and incorporated into food 
products without losing viability and functionality. It 
must maintain that viability through storage to the 
end of the shelf life of the food and should not create 
unpleasant flavors or textures. It must also survive pas-
sage through the upper gastrointestinal (GI) tract and 
arrive alive at its site of action, and it must be able to 
function in the gut environment (Mattila-Sandholm et 
al., 2002). 
 Yogurts and other fermented milks have been used as 
delivery systems for probiotic cultures, although cheese 
has been suggested as a better carrier because of bet-
ter survival of the probiotic culture during storage and 
through the GI tract (Ong et al., 2006; Sharp et al., 
2008). Various cheeses have been investigated, includ-
ing Cheddar (Stanton et al., 1998; Phillips et al., 2006), 
low-fat Cheddar (Sharp et al., 2008), Gouda (Gomes et 
al., 1998), cottage cheese (Heller, 2001), Turkish white 
cheese (Kasimoglu et al., 2004), Argentinean cheese 
(Bergamini et al., 2006), and Kaúar (Ozer et al., 2008). 
Whether probiotic bacteria can survive in cheeses that 
are exposed to a severe heat treatment (such as the 
pasta filata process used during manufacture of Moz-
zarella cheese) has not been reported. It is also difficult 
to properly enumerate probiotic bacteria in cheese by 
using selective media when high numbers of other lactic 
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acid bacteria (LAB) are present (Oberg et al., 2011) 
unless the probiotic culture contains a biomarker that 
allows its specific enumeration (Sharp et al., 2008).
The pH and reduced oxygen levels of cheese make 
it suitable for long-term survival of probiotic bacteria 
(Boylston et al., 2004; Phillips et al., 2006). In contrast, 
lower pH and higher oxygen levels in a liquid matrix, 
such as fermented milks and yogurt, may not maintain 
sufficient numbers (i.e., >107 viable cell/g) of the pro-
biotic bacteria (such as some strains of Bifidobacterium 
spp.) through to the end of the shelf life (Gardiner et 
al., 1999; Shah, 2000). It has also been suggested that 
the high buffering capacity and lipid content of cheese 
provide protection to probiotic bacteria in the GI tract 
(Phillips et al., 2006). Thus, cheese could deliver viable 
probiotics in sufficient numbers to provide therapeutic 
effects through the entire shelf life (Burns et al., 2008).
To exert a health benefit via action in the distal 
ileum and colon, probiotic bacteria must survive pas-
sage through the esophagus, a highly acidic stomach, 
and an alkaline small intestine (Naidu et al., 1999). 
Losses of up to 6 to 9 log cfu/g of probiotic bacte-
ria in simulated gastric digestion have been reported 
(Sabikhi et al., 2010; Ortakci, 2010), depending on the 
bacterial strain and testing conditions. Immobilization 
of bacteria within an encapsulating matrix has been 
investigated as a means of reducing cell injury or loss 
and improving their survival in foods (Kailasapathy, 
2006; Muthukumarasamy and Holley, 2006; Ozer et al., 
2009; Ortakci, 2010; Brinques and Ayub, 2011) and 
during gastric digestion (Chandramouli et al., 2004; Pi-
cot and Lacroix, 2004; Muthukumarasamy et al., 2006; 
Ding and Shah, 2009; Pimentel-González et al., 2009; 
Ortakci, 2010; Brinques and Ayub, 2011).
To be effective, capsules should maintain integrity in 
the foodstuff and during digestion and passage though 
the GI tract, after which they should break down and 
release their contents. Different types of encapsulating 
materials have been used to trap probiotic bacteria. The 
most common is alginate because it has the benefits of 
being nontoxic, easy to form into a gel, and readily 
available (Ding and Shah, 2009). Mixing an aqueous 
Na-alginate-bacterial suspension with vegetable oil can 
create a water-in-oil emulsion that, when treated with 
Ca, solidifies into beads (Sheu and Marshall, 1993) of 
0.025 to 2 mm in diameter, depending on shear rate 
(Krasaekoopt et al., 2003).
Reports have been conflicting on the effectiveness of 
alginate encapsulation of probiotic bacteria to increase 
survival in simulated gastric juice (SGJ). Hansen et al. 
(2002) found no improvement in the survival of acid-
sensitive bifidobacteria incubated in SGJ at pH 2, 4, 
or 6 when using alginate microspheres with diameters 
of <100 μm. Krasaekoopt et al. (2004) also reported 
no increased survival of alginate-encapsulated Bifido-
bacterium bifidum in HCl-SGJ at pH 1.55. In contrast, 
Muthukumarasamy et al. (2006), who encapsulated 5 
different strains of Lactobacillus reuteri in 2% alginate 
using small (~40-μm) or large (~2-mm) capsules, re-
ported a protective effect in SGJ at pH 1.5 (0.08 M 
HCl, 0.2% NaCl). Using the same SGJ, Ortakci (2010) 
observed a similar effect with ~2-mm alginate capsules 
containing Lactobacillus acidophilus ATCC 4356, with 
a ~3-log reduction in encapsulated bacteria compared 
with no survival (>7-log reduction) of free Lb. acidophi-
lus ATCC 4356 under the same conditions.
This study investigated the survival of the probiotic 
Lactobacillus paracasei during the manufacture and 
storage of low-moisture part-skim Mozzarella cheese, 
and whether encapsulating the bacteria in alginate 
microcapsules would increase their survival. Some ques-
tion remains regarding whether the reported benefits 
of using cheese to deliver probiotic cultures is an in-
herent function of the cheese or a consequence of how 
survival in the human digestive tract is simulated and 
measured. To elucidate such survival using cheese as a 
delivery mechanism, the cheese was added to simulated 
gastric juice of various acidic conditions (and a simu-
lated intestinal juice) and then bacterial survival was 
measured.
MATERIALS AND METHODS
Materials
Lactobacillus paracasei ssp. paracasei LBC-1e, an 
erythromycin-resistant derivate (Broadbent et al., 
2004) of the probiotic strain LBC-1 (Cargill, Wauke-
sha, WI), was obtained from the culture collection 
of Jeffrey Broadbent (Utah State University, Logan). 
Streptococcus thermophilus starter culture TS-10C was 
donated by DSM Food Specialties USA Inc. (Eagleville, 
PA). Sodium alginate, Tween-80, erythromycin, and 
bile salts were purchased from Sigma-Aldrich Co. (St. 
Louis, MO); Elliker’s agar, de Man, Rogosa, and Sharpe 
(MRS) broth, and agar were from Becton Dickinson 
(Franklin Lakes, NJ); peptone was from EMD Chemi-
cals Inc. (Gibbstown, NJ); pepsin was from Mallinck-
rodt Baker Inc. (Phillipsburg, NJ); pancreatin was from 
Spectrum Chemical Mfg. Co. (New Brunswick, NJ); 
and corn oil (Western Family Foods Inc., Portland, OR) 
was from a local supermarket. The CaCl2·H2O, HCl, 
NaCl, NaH2PO4, and Na2HPO4 were analytical reagent 
grade. Double-strength chymosin rennet (Maxiren) was 
from DSM Food Specialties USA Inc., and fluorescein 
isothiocyanate (FITC) was from Sigma-Aldrich Co. 
The SYTO 9 used was a component of a LIVE/DEAD 
BacLight bacterial viability kit (Invitrogen, Carlsbad, 
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CA). Microscope slides were from Mercedes Medical 
(Sarasota, FL), and the Taylor Lube petroleum gel was 
from Haynes Manufacturing Co. (Westlake, OH).
Bacterial Growth Conditions
Working cultures of LBC-1e were prepared from fro-
zen stocks stored at −70°C by sequential transfer twice 
into MRS broth containing 3 μg/mL of erythromycin, 
in which the cultures were incubated anaerobically at 
37°C for 18 h. After incubation overnight, the media 
containing cells were centrifuged at 4,250 × g for 10 
min at 4°C, following which the supernatant was re-
moved and the cells were further washed twice (4,250 × 
g for 10 min at 4°C) with sterile 0.1% (wt/vol) peptone 
water. The washed cells were suspended to ~1010 cfu/
mL in saline-peptone water by comparing the optical 
density with a previously prepared standard curve (R2 
≥ 0.9; data not shown).
Microencapsulation
Bacterial cells were microencapsulated in alginate by 
the modified emulsion method of Sheu and Marshall 
(1993). Briefly, 200 mL of cell suspension (~1010 cfu/
mL) was mixed with 800 g of a 25 g/kg Na-alginate 
solution with continuous stirring at 400 rpm for 10 min 
to entrap bacteria. The alginate-culture mixture was 
then added dropwise through a 50-mL sterile syringe 
fitted with a needle into 5 kg of corn oil containing 
0.2% (wt/vol) Tween-80 with stirring (~500 rpm). 
When the oil-alginate mixture formed an emulsion, as 
was evident from the increasing turbidity, a sterile 0.2 
M CaCl2 solution was added immediately to polymer-
ize the alginate and break the emulsion. After 30 min, 
the Ca-alginate microcapsules formed were collected by 
vacuum filtration through Whatman #4 filter paper 
(Whatman International, Maidstone, UK), washed 
twice in 0.2 M CaCl2, and then stored in peptone-saline 
solution at 4°C until use.
Mozzarella Cheese Manufacture
Fresh bovine milk was obtained from Utah State Uni-
versity’s George B. Caine Dairy Research and Teach-
ing Center (Wellsville, UT) and was standardized to 
a protein:fat ratio of 1.2 and pasteurized at 73°C for 
15 s in the Gary Haight Richardson Dairy Products 
Laboratory. Two 16-kg portions of milk were warmed 
to 35°C in small stainless steel vessels, 1 g of starter 
culture was added to each, and the milk was ripened 
for 60 min. The milk was then renneted by adding 4 
mL of chymosin. The milk was stirred for ~2 min, and 
the adjunct probiotic culture was quickly added as ei-
ther 10 g of broth containing free LBC-1e cells (~1 × 
1010 cfu/g) or 360 g of encapsulated LBC-1e (~5 × 108 
cfu/g). The milk was stirred and then allowed to coagu-
late. After 15 min, the curd was cut using wire knives 
(16-mm spacing), healed for 10 min, and then stirred 
and heated to 41°C. With continued stirring, one-third 
portions of whey were removed after 15 and 35 min, 
and the whey was drained down to the curd level after 
a further 10 min. The curd was stirred for 10 min and 
washed with 13°C water to cool the curd to 22°C; it was 
then drained and salted at 10 g/kg.
Each batch of curd (containing either free or encap-
sulated LBC-1e) was divided into three 550-g portions, 
and a sample was collected for bacterial enumeration. 
Each replicate portion of curd was stretched in an ex-
cess amount of hot 70°C brine (containing 50 g/kg of 
NaCl) for about 1 min to heat the curd to 55 ± 1°C 
and held for 2 min. The hot cheese was then placed 
in a stainless steel mold and immersed in iced brine 
(containing 50 g/kg of NaCl and 3 g/kg of CaCl2) for 
2 h. The temperature of the cheese blocks decreased 
to ~24°C in 30 min, ~12°C after 1 h, and to 6°C by 
2 h. Each block of cold cheese was sampled for bacte-
rial enumeration, and then cut into 4 pieces, vacuumed 
packaged, and stored at 4°C.
Bacterial Enumeration
Bacteria were enumerated from Mozzarella cheese 
containing free LBC-1e after mixing 25 g of cheese 
with 225 mL of 0.1% peptone water at 230 rpm for 
10 min (Model 400 stomacher; Seward, London, UK). 
For cheese containing encapsulated LBC-1e, 0.2 M 
phosphate buffer (pH 7) was used in place of peptone 
water to disrupt the alginate gel and release the encap-
sulated bacteria. Total LAB were enumerated on MRS 
agar with the pour-plate method and were incubated 
anaerobically at 37°C for 48 h. The LBC-1e was selec-
tively enumerated on MRS agar containing 3 μg/mL of 
erythromycin.
Simulated Gastric Digestive
To investigate the influence of pH on the survival of 
probiotic bacteria, sterile filtered SGJ (based on that 
used by Mainville et al., 2005) containing 2.0 g/kg of 
NaCl and 0.3 g/kg of pepsin was prepared using HCl. 
To provide pH of the SGJ-cheese mixture similar to 
the physiological pH of the human stomach (~pH 1.4), 
SGJ-1 was made using 0.1 M HCl with a cheese:SGJ 
ratio of 1:6. For SGJ-2, the same acid concentration 
was used but the cheese:SGL ratio was changed to 1:4, 
and then to simulate physiological conditions in which 
further acid is secreted into the stomach after food in-
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gestion, additional HCl was added during incubation of 
the SGJ-cheese mixture to maintain pH <3. To further 
test the effect of pH on bacterial survival and allow a 
greater increase in pH after adding the cheese, SGJ-3 
was then made using 11 mM HCl. An additional acid 
digestion test (SGJ-4) was performed using 87 mM 
H3PO4 (pH 2.0) instead of HCl as a comparison with 
the report of Sharp et al. (2008) [Sharp et al. (2008) 
incorrectly reported the strength of the H3PO4 they 
used as 8.7 mM.] Before adding cheese, the SGJ were 
tempered to 37°C. The mixture was then stomached for 
10 min at 230 rpm and held at 37°C for up to 2 h with 
periodic shaking.
Simulated Intestinal Digestive
After treating the cheese for 60 min in 0.1 M HCl 
(SGJ-1), the mixture was converted to simulated in-
testinal juice (SIJ; Huang and Adams, 2004; Annan 
et al., 2008) by adding to 36 mL of the mixture 1 mg/
mL pancreatin and 4.5 g/mL of bile salts suspended in 
phosphate buffer, and then adjusting to pH 7.4 with 0.1 
M NaOH. The cheese-SIJ mixture was then incubated 
for 4 h at 37°C with periodic shaking.
Microstructure
Thin slices (~10 × 10 × 3 mm) of Mozzarella cheese 
mounted on microscope slides were treated with 5 g/L 
of FITC in an acetone:water (1:1) solution to stain for 
protein. The sample was rinsed twice with water and 
then treated with 3.34 mM of the SYTO 9 fluorophore. 
Stained samples were mounted on standard microscope 
slides with glycerin jelly and then examined using an 
inverted laser scanning confocal microscope (BioRad, 
Hercules, CA) with an Ar/Kr laser that provided ex-
citation of both FITC and SYTO 9 at a wavelength of 
488 nm. Emissions from the fluorophores were captured 
sequentially using filters of wavelengths 512 to 532 nm 
for SYTO 9 and ≥585 nm for FITC.
Statistical Analysis
Logarithmic reductions in bacterial numbers as a 
consequence of hot water stretching and chemical 
analysis results of both cheese samples were analyzed 
by one-way ANOVA and Tukey’s multiple comparison 
test (PROC GLIMMIX; SAS Institute Inc., Cary, NC) 
with 3 replicates. Logarithmic reductions in bacterial 
numbers during storage and as a consequence of SGJ 
or SIJ incubation were analyzed using repeated mea-
surement and Tukey’s multiple comparison test (PROC 
GLIMMIX; SAS Institute Inc.) as a 2-way factorial with 
encapsulation as the treatment effect with 3 replicates. 
Significance was declared at P ≤ 0.05.
RESULTS AND DISCUSSION
Cheese Composition
The cheeses had similar moisture of 55.5 and 55.6% 
and pH of 5.39 and 5.41, respectively, for cheese con-
taining free or encapsulated bacteria. A slightly lower 
fat content (12.5 vs. 15.8%) and higher salt content 
(1.88 vs. 1.70%) were observed (P < 0.05) for the 
cheese with the encapsulated bacteria. These differ-
ences were not expected to influence bacterial survival 
and were assumed to relate to the presence of the al-
ginate microcapsules during milk coagulation and curd 
manufacture.
As shown in Figure 1, the microcapsules containing 
the LBC-1e bacteria (A) were located in the serum 
and fat pockets that form within the curd structure 
as the protein matrix forms and that contract as a 
consequence of renneting, acid development and curd 
agitation, and cooking. During the hot-water stretching 
process, the fat droplets are then oriented into channels 
concomitantly with the protein matrix forming into 
fibrous strands (Oberg et al., 1993).
Cheese Manufacture and Storage
Initial numbers of total LAB in the cheese curd were 
8.3 × 108 and 2.2 × 109 cfu/g for curds that contained 
free and encapsulated bacteria, respectively (Table 1). 
Included in this enumeration were the St. thermophilus 
starter culture and the LBC-1e probiotic culture. Ad-
dition of LBC-1e to milk had been planned to provide 
about 1 × 109 cfu/g of bacteria per 28-g serving of 
cheese, assuming the concentration of bacteria would 
be 10-fold during conversion of milk into curd, with an 
allowance for potential loss of microcapsules by sedi-
mentation before coagulation. The number of LBC-1e 
added to the milk had been estimated at ~6 × 106 
and ~1 × 107 cfu/g of free and encapsulated bacteria, 
respectively, and the amount measured in the cheese 
curd was 6.6 × 107 and 5.4 × 108 cfu/g, respectively. 
Thus, less loss of encapsulated bacteria occurred during 
the coagulation process than anticipated, and the 2 sets 
of cheese curd contained above the target of 3.61 × 107 
cfu/g.
When the curd was immersed and stretched in hot 
water, the bacterial numbers decreased slightly (Table 
1). Total LAB had mean log reductions of 0.20 and 
0.40 for the control and encapsulated treatments, re-
spectively. The extent of decrease for total LAB was 
not significantly different (P = 0.095) in the control 
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cheese but was in the cheese containing the encapsu-
lated bacteria. The survival of encapsulated LBC-1e 
bacteria was slightly higher (P = 0.012) than that in 
cheese containing free bacteria, with log reductions of 
0.25 and 0.45, respectively.
During 42-d storage, no decrease (P = 0.84) was 
observed in the number of either free or encapsulated 
LBC-1e (Table 1) in the Mozzarella cheese, as has been 
shown for Cheddar cheese storage (Stanton et al., 1998; 
Gardiner et al., 1999; Sharp et al., 2008). However, the 
total LAB numbers decreased significantly (P < 0.0001) 
during the storage period, indicating that a slow die-off 
of residual starter St. thermophilus bacteria occurred 
after the first week of refrigerated storage.
Simulated Gastric Digestion
The extent of die-off of bacteria when the cheese was 
incubated in HCl-based SGJ was a function of both 
acid concentration and the extent of neutralization of 
acid upon cheese addition. When cheese was incubated 
in SGJ-1 (0.1M HCl, pH 0.65, cheese:SGJ ratio of 1:6), 
the LBC-1e numbers decreased by 4.2 log after a 60-min 
incubation (Table 2). Initial mean bacteria counts were 
5.6 × 107 and 3.5 × 108 cfu/g for free and encapsulated 
LBC-1e, and after 1 h they had declined to 4.7 × 103 
and 2.7 × 104 cfu/g, respectively (P < 0.0001).
After adding the cheese, the pH of the mixture had 
increased to pH 1.4, which is similar to the pH of the 
human stomach before ingestion of food. In such a harsh 
environment, no protection was provided by encapsula-
tion of the bacteria in Ca-alginate. This agrees with 
the reports of Hansen et al. (2002) and Krasaekoopt 
et al. (2004) rather than that of Muthukumarasamy et 
al. (2006). Because protection has been observed when 
using large macrocapsules (Ortakci, 2010), it appears 
that size of the capsules influences the protective effect 
of alginate encapsulation. It may be that in larger (~2-
mm) capsules, a die-off of bacteria occurs in the outer 
regions, which are more exposed to the acid, whereas 
the bacteria in the inner regions are protected. This 
would explain the ~3-log reduction observed in macro-
encapsulated Lb. acidophilus while free bacteria showed 
no survival (>7-log loss; Ortakci, 2010).
When a greater proportion of cheese was added (such 
as in SGJ-2), the pH of the cheese-SGJ mixture in-
Figure 1. Laser scanning confocal micrograph of Mozzarella cheese 
containing alginate-encapsulated Lactobacillus paracasei LBC-1e 
with protein imaged using fluorescein isothiocyanate (Sigma-Aldrich 
Inc., Saint Louis, MO; gray), bacterial cells imaged using SYTO 9 
(Invitrogen, Carlsbad, CA; white), and serum pockets and fat not be-
ing stained (black). A: Microcapsule containing LBC-1e located in a 
serum pocket; B: Streptococcus thermophilus starter culture distributed 
throughout the protein matrix.
Table 1. Mean microbiological counts (cfu/g) for total lactic acid bacteria (LAB) and added Lactobacillus 
paracasei LBC-1e (LBC-1e) in Mozzarella curd (before hot stretching) and cheese during refrigerated storage 
for cheese in which LBC-1e was added to milk before renneting as free (control) or alginate-encapsulated 
bacteria1 
Time (d)
Total LAB LBC-1e
Control Encapsulated Control Encapsulated
02 (curd) 8.19 × 108 1.78 × 109  5.98 × 107 5.37 × 108
03 (cheese) 5.00 × 108 6.62 × 108  2.11 × 107 3.16 × 108
7 6.61 × 108 1.82 × 109  2.46 × 107 3.44 × 108
21 2.24 × 108 7.38 × 108  3.75 × 107 2.55 × 108
42 2.23 × 108 7.13 × 108  3.18 × 107 2.50 × 108
1The total LAB includes the Streptococcus thermophilus starter culture, free or encapsulated LBC-1e, respec-
tively, and any nonstarter LAB present in the cheese.
2Before the hot stretching process of curd.
3After the hot stretching process of curd.
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creased above that maintained in the stomach, primar-
ily because of the buffering capacity of the protein and 
phosphate in the cheese. By periodically adding 0.1 M 
HCl during incubation, this buffering effect was coun-
tered and the final pH of SGJ-2 was 2.3. Under these 
conditions, survival of bacteria was greater compared 
with that in SGJ-1, and numbers of free and encap-
sulated LBC-1e in SGJ-2 decreased from initial mean 
values of 1.5 × 107 and 2.6 × 108 cfu/g to 1.5 × 105 
and 1.1 × 107 cfu/g, respectively, after a 2-h incubation 
(P < 0.0001). Again, no protection was observed on 
bacterial survival in SGJ-2 provided by encapsulation.
The loss of bacteria after a 2-h incubation in 11 mM 
HCl (SGJ-3) was minimal, with 90% of LBC-1e sur-
viving (i.e., only ~1-log reduction) for both free and 
encapsulated bacteria. Initial mean counts were 3.29 
× 107 and 2.55 × 108 cfu/g for free and encapsulated 
bacteria, respectively, and these had declined to 3.14 × 
106 and 1.08 × 107 cfu/g after incubation (P < 0.0001). 
Such survival can be attributed to buffering of SGJ-
3 by the cheese, and it was observed that pH of this 
gastric solution increased to pH ≥4 within 2 min. This 
supports the notion that the matrix in which the bac-
teria are present can influence their survival, as shown 
by Sharp et al. (2008), and that bacteria, as a liquid 
culture, are not protected as effectively as when present 
in a semisolid matrix. This explains why Gardiner et 
al. (1999) found no reduction in probiotic bacteria in 
Cheddar cheese after a 2-h incubation in porcine gastric 
juice that had an initial pH of 2.0 and a final pH of 
4.74. It is important in such simulated testing that the 
SGJ match the proper physiological conditions because 
bacterial survival is influenced by the pH (Mainville 
et al., 2005; Pitino et al., 2010) encountered by the 
probiotic bacteria when ingested.
We have shown that the buffering effect of a food that 
is delivering probiotic bacteria can influence bacterial 
survival when tested in vitro using an acid medium 
to simulate gastric contents of the human stomach. 
However, such buffering provides an artifactual result 
because in vivo in a healthy individual, additional acid 
is secreted into the stomach to maintain acidity at or 
below ~pH 2. Under such conditions, a 4-log reduc-
tion in bacterial numbers can be expected in foods with 
greater reductions occurring when bacteria are ingested 
in a nonprotected form.
When acid tolerance of LBC-1e was tested using 
phosphoric acid (SGJ-4) so that buffering effects of 
the cheese would be negated, bacteria again had very 
poor survival (P < 0.0001) in the control Mozzarella 
cheese containing free LBC-1e. The pH of SGJ-4 re-
mained ~2 during incubation, and mean numbers of 
free LBC-1e fell from an initial level of 3.3 × 107 cfu/g 
to 2.0 × 103 cfu/g after incubation (P < 0.0001; Table 
2). This agrees with the report of Sharp et al. (2008), 
who observed a 3.8-log reduction after a 2-h incuba-
tion in SGJ-4 of a low-fat Cheddar cheese containing 
Lb. paracasei 334e. It is interesting that greater sur-
vival was observed when the bacteria were present in 
cheese in encapsulated form (Table 2). Mean numbers 
of LBC-1e were 2.6 × 108 cfu/g before incubation and 
remained at 2.3 × 107 cfu/g after the 2-h incubation 
(P < 0.0001).
The in vitro test of gastric survival using H3PO4 
(SGJ-4) was useful to provide a buffering effect when 
the bacteria were present in a free form, but it was not 
a good test for acid tolerance of the bacteria in the 
alginate microcapsules. Some interaction between the 
H3PO4 and Ca-alginate capsules possibly may have pre-
vented penetration of acid into the capsules. As shown 
in SGJ-2, in which HCl was replenished during incuba-
tion so as to maintain acid conditions of the cheese-
SGJ mixture, encapsulation was unable to provide any 
significant protective effect for the bacteria.
Table 2. Mean loss (n = 3) of free (control) and encapsulated Lactobacillus paracasei LBC-1e in Mozzarella cheese after incubation in simulated 
gastric juice (SGJ) and simulated intestinal juice (SIJ) 
Juice Composition Ratio1 Time (min)
pH Loss during incubation (log10 cfu/g)
Initial Final Control Encapsulated
SGJ-1 0.1M HCl 1:6 60 0.65 1.4  3.77a,x 4.20a,x
SGJ-2 0.1M HCl2 1:4 120 0.65 2.3  1.88b,x 1.50b,x
SGJ-3 0.01M HCl 1:6 120 1.5 4.4  1.03c,x 1.13b,x
SGJ-4 0.9M H3PO4 1:9 120 2.0 2.2  3.80
a,y 1.05b,x
SIJ3 Bile and pancreatin 1:6 240 7.4 7.4  0d,x 0c,x
a–dMeans within a column with the same letters are not significantly different (α = 0.05).
x,yMeans within a row with the same letters are not significantly different (α = 0.05).
1Ratio of cheese added to simulated gastric solutions.
2Additional 0.1M HCl was added to SGJ-2 during incubation to maintain pH <2.5.
3Survival in SIJ was determined by adding 1 mg/mL of pancreatin and 4.5 g/mL of bile salts suspended in phosphate buffer after incubating 
cheese in SGJ-1 for 60 min, then adjusting pH to 7.4 with 0.1 M NaOH.
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When the cheese-SGJ-1 mixture was neutralized and 
bile and pancreatin were added to form SIJ, a slight 
increase in bacterial numbers to 4.7 × 103 and 2.7 × 
104 cfu/g was observed for the free and encapsulated 
bacteria, respectively, probably because of resuscitation 
of some cells that were sublethally injured during the 
1-h incubation of SGJ-1. Incubation of the cheese-SIJ 
mixture for 4 h at 37°C did not significantly affect 
survival of either free or encapsulated LBC-1e (Table 
2), indicating a natural bile resistance of this probiotic 
strain.
In the present study, using cheese as a delivery sys-
tem has a positive effect on survivability of the bacteria 
because of its buffering effect and possibly because it 
may provide a protective environment to the probiotic 
bacteria (Ruass-Madiedo et al., 2002). Compared with 
yogurt and other fermented milks, the higher buffer-
ing capacity of the cheese, the higher fat content, and 
the tight matrix may improve the survival of bacteria 
in the stomach and intestines (Heller, 2001). It is well 
known that ingesting bacteria that have been incorpo-
rated into food improves their viability during GI pas-
sage (Zárate et al., 2000; Huang and Adams, 2004). We 
agree with Mainville et al. (2005) on the importance of 
incorporating bacteria into a food matrix so that the 
bacteria can be protected from the harsh environment 
of the human digestive tract and reach their site of 
action in sufficiently high numbers.
The Food and Agriculture Organization of the 
United Nations/World Health Organization (FAO/
WHO, 2002) has made a general recommendation that 
a probiotic food should contain 106 to 107 cfu/g so that 
a 100-g serving would provide 108 to 109 cfu that were 
ingested. However, dose-response studies supporting 
this number are sparse; the number of probiotic bac-
teria that would ensure an effect has not been stan-
dardized, and this number is actually strain and effect 
dependent (Rowland et al., 2010). With ingestion of 
109 cfu of probiotic bacteria as an isolated culture, no 
survival after passage through the stomach would be 
expected, and perhaps only 102 cfu would be expected 
in a liquid or soft-gel food, such as yogurt (Sharp et 
al., 2008), when the pH is held constant during incuba-
tion in SGJ. If the probiotic culture is delivered in a 
hard gel, such as cheese, the expected survival after 
gastric passage would be 105. Thus, by having 109 cfu/
serving of a probiotic organism in cheese, 100- to 1,000-
fold more living cells of the bacteria would survive 
in the intestinal tract, where it needs to be present 
to have any beneficial health effect. If the aim is to 
deliver 104 bacteria/g to the intestines, this could be 
achieved beginning with as little as 106 cfu/g in cheese 
because only a 2-log reduction during simulated gastric 
digestion occurred when pH was maintained similarly 
to physiological conditions and some buffering occurs. 
This would have a dramatic effect on reducing the cost 
of producing probiotic foods.
CONCLUSIONS
Hot stretching during Mozzarella cheese manufacture 
caused slight log reductions of 0.4 and 0.2 in the num-
bers of free and encapsulated Lb. paracasei LBC-1e, 
respectively. Refrigerated storage did not make any 
difference in the numbers of free and gel encapsulated 
LBC-1e; however, during storage, the total LAB num-
bers in both cheeses (predominantly the starter St. 
thermophilus bacteria) decreased significantly. Encap-
sulation did not increase the survival in SGJ containing 
HCl. Survival of LBC-1e was dependent on pH of the 
SGJ-cheese mixture. We observed mean log reductions 
of 4.0, 1.5, and 1.1 when the final pH of SGJ reached 
pH 1.4, 2.3, and 4.4, respectively. This shows the impor-
tance of selecting the proper conditions for simulating 
gastric digestion and when comparing various research 
results using SGJ. It was unexpected that alginate en-
capsulation increased the survival of LBC-1e in H3PO4 
SGJ, although the reason for this is not known.
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